Eric W. Thomas

Array ( [id] => 6420809 [patent_doc_number] => 20100150960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/442483 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24277 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150960.pdf [firstpage_image] =>[orig_patent_app_number] => 12442483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373728 [patent_doc_number] => 20090311289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 12/310966 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 49069 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311289.pdf [firstpage_image] =>[orig_patent_app_number] => 12310966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7534809 [patent_doc_number] => 08048431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Modified HIV-1 clade C envelope glycoprotein immunogens comprising deletions in the gp120/gp41 cleavage site and gp41 fusion domain' [patent_app_type] => utility [patent_app_number] => 11/896934 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 227 [patent_figures_cnt] => 302 [patent_no_of_words] => 21413 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048431.pdf [firstpage_image] =>[orig_patent_app_number] => 11896934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152495 [patent_doc_number] => 08168772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling' [patent_app_type] => utility [patent_app_number] => 11/897320 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 126607 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168772.pdf [firstpage_image] =>[orig_patent_app_number] => 11897320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302391 [patent_doc_number] => 20100068217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'EPITOPE-TRANSPLANT SCAFFOLDS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/438913 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 30731 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12438913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431465 [patent_doc_number] => 20100143402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'INTERGENIC SITES BETWEEN CONSERVED GENES IN THE GENOME OF MODIFIED VACCINIA ANKARA (MVA) VACCINIA VIRUS' [patent_app_type] => utility [patent_app_number] => 12/377847 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 17214 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143402.pdf [firstpage_image] =>[orig_patent_app_number] => 12377847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4594983 [patent_doc_number] => 07981430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome' [patent_app_type] => utility [patent_app_number] => 11/844301 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 35694 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981430.pdf [firstpage_image] =>[orig_patent_app_number] => 11844301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718613 [patent_doc_number] => 20080241135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Methods for reducing viral load in HIV-1-infected patients' [patent_app_type] => utility [patent_app_number] => 11/894762 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 31458 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241135.pdf [firstpage_image] =>[orig_patent_app_number] => 11894762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080276 [patent_doc_number] => 20110142911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'HIV epitopes and pharmaceutical composition containing same' [patent_app_type] => utility [patent_app_number] => 11/894172 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8461 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142911.pdf [firstpage_image] =>[orig_patent_app_number] => 11894172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785568 [patent_doc_number] => 20080138897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Method for preventing HIV-1 infection of CD4+ Cells' [patent_app_type] => utility [patent_app_number] => 11/894568 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12002 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138897.pdf [firstpage_image] =>[orig_patent_app_number] => 11894568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290060 [patent_doc_number] => 20100158945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'ATTENUATED POLIO VIRUSES' [patent_app_type] => utility [patent_app_number] => 12/377041 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5665 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158945.pdf [firstpage_image] =>[orig_patent_app_number] => 12377041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955616 [patent_doc_number] => 20080188640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Immunodeficiency recombinant poxvirus' [patent_app_type] => utility [patent_app_number] => 11/891027 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 129 [patent_figures_cnt] => 129 [patent_no_of_words] => 49012 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188640.pdf [firstpage_image] =>[orig_patent_app_number] => 11891027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687691 [patent_doc_number] => 20080031872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'HIV immunogenic composition and method of administration' [patent_app_type] => utility [patent_app_number] => 11/888471 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4620 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031872.pdf [firstpage_image] =>[orig_patent_app_number] => 11888471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797131 [patent_doc_number] => 20080008717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus' [patent_app_type] => utility [patent_app_number] => 11/828272 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13546 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008717.pdf [firstpage_image] =>[orig_patent_app_number] => 11828272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191541 [patent_doc_number] => 09422342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Recoding method that removes inhibitory sequences and improves HIV gene expression' [patent_app_type] => utility [patent_app_number] => 12/373605 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17863 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662300 [patent_doc_number] => 20110311569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'HIV-1 Peptides, Nucleic Acids, and Compositions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/309256 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13279 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311569.pdf [firstpage_image] =>[orig_patent_app_number] => 12309256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771417 [patent_doc_number] => 20080057075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Method of inducing neutralizing antibodies to human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 11/812992 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9657 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057075.pdf [firstpage_image] =>[orig_patent_app_number] => 11812992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583722 [patent_doc_number] => 20100047765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'MOLECULAR DETERMINANTS ASSOCIATED WITH ENHANCED ABILITY TO ENTER CELLS EXPRESSING CXCR4' [patent_app_type] => utility [patent_app_number] => 12/304418 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19724 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047765.pdf [firstpage_image] =>[orig_patent_app_number] => 12304418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463855 [patent_doc_number] => 09580473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Method of inhibiting HIV-1 binding to genital epithelia using V3 loop-specific peptides and GP340-specific antibodies' [patent_app_type] => utility [patent_app_number] => 12/303985 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 14604 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231340 [patent_doc_number] => 20070293448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'SYNTHETIC GAGPOL GENES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 11/754755 [patent_app_country] => US [patent_app_date] => 2007-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15182 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293448.pdf [firstpage_image] =>[orig_patent_app_number] => 11754755 [rel_patent_id] =>[rel_patent_doc_number] =>)